AI Assistant
Blog
Pricing
Log In
Sign Up
Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
